Skip to main content
. 2021 Mar 4;2021(3):CD010172. doi: 10.1002/14651858.CD010172.pub3

ChiCTR1800014553.

Study name Comparative study of nasal high‐flow oxygen therapy and noninvasive positive pressure ventilation for moderate AECOPD: randomized open non‐inferiority trial
Methods RCT, parallel‐group design
Participants Total number of participants: 86
Setting: China
Inclusion criteria: AECOPD; blood gas analysis pH 7.25‐7.35, PaCO2 > 50 mmHg
Exclusion criteria: age < 18; no informed consent obtained; severe respiratory failure requiring tracheal intubation; NPPV contraindications; patients with short‐term prognosis; other organ failure; tracheotomy
Interventions Intervention group (HFNC)
Control group (NPPV)
Outcomes All outcomes measured: arterial blood gas, respiratory rate, blood pressure, daily treatment time; parameter setting of NPPV and HFNC; change and time of respiratory support; intubation; time to intubation; dyspnoea score; comfort score; facial skin breakage; number of daily nursing interventions; respiratory and extrapulmonary complications; ICU length of stay; hospital length of stay; discharge outcome (death, improved)
Outcomes relevant to this review: arterial blood gas, respiratory rate, intubation; dyspnoea score; comfort score; respiratory and extrapulmonary complications; ICU length of stay; hospital length of stay; mortality
Starting date 21 January 2018
Contact information Dingyu Tan, 32494845@qq.com. Bingyu Ling
Notes